Search results
Qualcomm Stock Is Nearly Back to Its All-Time High -- Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 5 days agoClearly, investors are feeling optimistic about Qualcomm, but what's driving the stock higher, and...
Scott Farquhar Sells 8,241 Shares of Atlassian Co. (NASDAQ:TEAM) Stock
ETF DAILY NEWS· 20 hours agoAtlassian Co. (NASDAQ:TEAM – Get Free Report) CEO Scott Farquhar sold 8,241 shares of the business’s stock in a transaction on Monday, April 22nd. The stock
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace· 2 days agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
EARTHSENE FPO [EE1] (ASX:EE1) Insider Acquires A$83,004.27 in Stock
ETF DAILY NEWS· 19 hours agoEARTHSENE FPO [EE1] (ASX:EE1 – Get Free Report) insider Grant Davey bought 6,384,944 shares of the...
7 Stocks That Will Keep Going Up During the Next Downturn
InvestorPlace· 15 hours agoThe next economic downturn might be closer than you think. For one, the recent inflation report came...
Telus Stock Is Down to its Pandemic Low of Below $22: How Low Can it Go?
MSN News· 4 days agoTelus stock is down 37% in two years and is trading near its pandemic low, making investors wonder...
Lindbrook Capital LLC Grows Stock Holdings in Okta, Inc. (NASDAQ:OKTA)
ETF DAILY NEWS· 17 hours ago:OKTA – Free Report) by 61.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 782 shares of the ...
Stealth Wealth Creators: 7 Overlooked Penny Stocks Ready to Explode
InvestorPlace· 1 day agoWhen dealing with speculative investments – especially overlooked penny stocks – prospective...
7 Battered Blue-Chip Stocks to Bounce From Your Portfolio This Spring
InvestorPlace· 7 days agoIf your blue-chip stocks are underperforming, you have a big problem. Blue-chip stocks represent the...
Avidity Biosciences, Inc. (NASDAQ:RNA) Director Sells $114,100.00 in Stock
ETF DAILY NEWS· 19 hours agoAvidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, April 19th ...